SCHERING logo 228 (Fulvicin P G ultramicrocrystalline 125 mg)

Generic Name: griseofulvin

Pill imprint SCHERING logo 228 has been identified as Fulvicin P G ultramicrocrystalline 125 mg.

Fulvicin P/G is used in the treatment of tinea capitis; dermatophytosis; onychomycosis, toenail; tinea barbae; tinea cruris (and more), and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy. Fulvicin P/G ultramicrocrystalline 125 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for SCHERING logo 228 (Fulvicin P G ultramicrocrystalline 125 mg)

Fulvicin P   G ultramicrocrystalline 125 mg SCHERING logo 228 Front
Fulvicin P   G ultramicrocrystalline 125 mg SCHERING logo 228 Back
Fulvicin P G
Generic Name:
griseofulvin
Imprint:
SCHERING logo
228
Strength:
ultramicrocrystalline 125 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antifungals
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Schering-Plough Corporation

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web1)